Epinephrine/Lidocaine Hydrochloride

肾上腺素/盐酸利多卡因

Report date: 2026/03/27 20:01:50

Base Information

Drug NameEpinephrine/Lidocaine Hydrochloride
Drug Alias NameAdrenaline - Lidocaine hydrochlorideEpinephrine - Lidocaine hydrochlorideXylocaine W-EpinephrineFLAVALTA
ClassificationSmall molecules
Mechanisms of ActionAdrenergic receptors agonistsSodium channel alpha subunit blockers
TargetsSodium channel alpha subunitAdrenergic receptors
Therapy Area/IndicationsAnesthesia
Global Approved IndicationsAnesthesia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1948/11/19
Country/TerritoryUnited StatesJapan
CombinationsYes AdrenalineLidocaine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesFresenius Kabi Ag
China Registration ClassN/A

Develop Information

Active CompaniesDeproco IncShowa Yakuhin Kako Co Ltd
Inactive CompaniesDentsply Pharm Lcex
Active IndicationsAnesthesia
Inactive IndicationsN/A

Other Information

ATC CodeN01BB52S01EA51
Related LinksWikipediaKEGG